Quantifying ternary mixtures of different solid-state forms of indomethacin by Raman and near-infrared spectroscopy.
暂无分享,去创建一个
Thomas Rades | Andrea Heinz | C. Strachan | T. Rades | M. Savolainen | A. Heinz | Clare J Strachan | Marja Savolainen
[1] L Yu,et al. Amorphous pharmaceutical solids: preparation, characterization and stabilization. , 2001, Advanced drug delivery reviews.
[2] J. Sjöblom,et al. Quantitative FT-Raman analysis of two crystal forms of a pharmaceutical compound. , 1997, Journal of pharmaceutical and biomedical analysis.
[3] M. Otsuka,et al. Evaluation of the Microcrystallinity of a Drug Substance, Indomethacin, in a Pharmaceutical Model Tablet by Chemometric FT-Raman Spectroscopy , 2005, Pharmaceutical Research.
[4] L. S. Taylor,et al. Evaluation of solid-state forms present in tablets by Raman spectroscopy. , 2000, Journal of pharmaceutical sciences.
[5] K R Morris,et al. Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing processes. , 2001, Advanced drug delivery reviews.
[6] D. Bugay,et al. Quantitation of cefepime.2HCl dihydrate in cefepime.2HCl monohydrate by diffuse reflectance IR and powder X-ray diffraction techniques. , 1996, Journal of pharmaceutical and biomedical analysis.
[7] G A Stephenson,et al. Characterization of the solid state: quantitative issues. , 2001, Advanced drug delivery reviews.
[8] H. Siesler,et al. Near-infrared spectroscopy:principles,instruments,applications , 2002 .
[9] Richard L. McCreery,et al. Raman Spectroscopy for Chemical Analysis , 2000 .
[10] Bruno C. Hancock,et al. Crystallization of indomethacin from the amorphous state below and above its glass transition temperature. , 1994, Journal of pharmaceutical sciences.
[11] Bruno C. Hancock,et al. What is the True Solubility Advantage for Amorphous Pharmaceuticals? , 2000, Pharmaceutical Research.
[12] J. Rantanen,et al. Improved Understanding of Factors Contributing to Quantification of Anhydrate/Hydrate Powder Mixtures , 2005, Applied spectroscopy.
[13] Thomas Rades,et al. Quantitative analysis of polymorphic mixtures of carbamazepine by Raman spectroscopy and principal components analysis , 2004 .
[14] R. J. Lehnert,et al. The dependence of Raman signal intensity on particle size for crystal powders , 1996 .
[15] C. Casolino,et al. Application of standardisation methods to correct the spectral differences induced by a fibre optic probe used for the near-infrared analysis of pharmaceutical tablets. , 1998, Journal of pharmaceutical and biomedical analysis.
[16] G. Zografi,et al. Crystal nucleation and growth of indomethacin polymorphs from the amorphous state , 2000 .
[17] Desire L. Massart,et al. Investigation of sources of variance which contribute to NIR-spectroscopic measurement of pharmaceutical formulations , 1997 .
[18] Jonas Johansson,et al. Infrared imaging of laser-induced heating during Raman spectroscopy of pharmaceutical solids. , 2002, Journal of pharmaceutical and biomedical analysis.
[19] N. Kaneniwa,et al. Physicochemical characterization of indomethacin polymorphs and the transformation kinetics in ethanol. , 1985, Chemical & pharmaceutical bulletin.
[20] Nils-Olof Lindberg,et al. Multivariate methods in pharmaceutical applications , 2002 .
[21] R. Barnes,et al. Standard Normal Variate Transformation and De-Trending of Near-Infrared Diffuse Reflectance Spectra , 1989 .
[22] P. Cox,et al. γ‐Indomethacin at 120 K , 2003 .
[23] Lynne S. Taylor,et al. Spectroscopic Characterization of Interactions Between PVP and Indomethacin in Amorphous Molecular Dispersions , 1997, Pharmaceutical Research.
[24] M. Pelletier,et al. Quantitative Analysis Using Raman Spectrometry , 2003, Applied spectroscopy.
[25] T. Nagai,et al. Stability and several physical properties of amorphous and crystalline form of indomethacin. , 1980, Chemical & pharmaceutical bulletin.
[26] K. Morris,et al. Raman spectroscopy for tablet coating thickness quantification and coating characterization in the presence of strong fluorescent interference. , 2006, Journal of pharmaceutical and biomedical analysis.
[27] R. D. Jee,et al. The application of multiple linear regression to the measurement of the median particle size of drugs and pharmaceutical excipients by near-infrared spectroscopy. , 1998, The Analyst.
[28] D. Grant. THEORY AND ORIGIN OF POLYMORPHISM , 1999 .
[29] G. Zografi,et al. The Quantitative Analysis of Crystallinity Using FT-Raman Spectroscopy , 1998, Pharmaceutical Research.
[30] Steven W Booth,et al. Quantitative analysis of mannitol polymorphs. FT-Raman spectroscopy. , 2002, Journal of pharmaceutical and biomedical analysis.
[31] T. Vickers,et al. Effect of Powder Properties on the Intensity of Raman Scattering by Crystalline Solids , 2002 .
[32] D. Bugay,et al. Utilization of Fourier transform-Raman spectroscopy for the study of pharmaceutical crystal forms. , 1998, Journal of pharmaceutical and biomedical analysis.
[33] N Kaneniwa,et al. A kinetic study of the crystallization process of noncrystalline indomethacin under isothermal conditions. , 1988, Chemical & pharmaceutical bulletin.
[34] K. Morris,et al. Reactivity differences of indomethacin solid forms with ammonia gas. , 2002, Journal of the American Chemical Society.
[35] P. Geladi,et al. Linearization and Scatter-Correction for Near-Infrared Reflectance Spectra of Meat , 1985 .
[36] Erik Johansson,et al. Mixture design—design generation, PLS analysis, and model usage , 1998 .
[37] H. Brittain. Polymorphism in Pharmaceutical Solids , 1999 .
[38] J. Curcio,et al. Near infrared absorption spectrum of liquid water , 1951 .
[39] M. Otsuka,et al. Determination of indomethacin polymorphic contents by chemometric near-infrared spectroscopy and conventional powder X-ray diffractometry. , 2001, The Analyst.
[40] D. Bugay. Characterization of the solid-state: spectroscopic techniques. , 2001, Advanced drug delivery reviews.
[41] A. Savitzky,et al. Smoothing and Differentiation of Data by Simplified Least Squares Procedures. , 1964 .
[42] R. E. Marsh,et al. Crystal and molecular structure of an antiinflammatory agent, indomethacin, 1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid. , 1972, Journal of the American Chemical Society.
[43] S. Wold,et al. PLS-regression: a basic tool of chemometrics , 2001 .